← Leaderboards
John E Wagner
University Of Minnesota
$7,593,142
Attributed
$7,593,142
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,556,661 · 12
By mechanism
P01$28,878,479 · 8
P30$580,695 · 3
N01$97,487 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Jeffrey S Miller$32,066,338
- Rachel R Hardeman$3,148,680
- Michele L Allen$11,384,036
- David H Ingbar$22,490,578
- Martin Felices$2,733,593
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsAllogenicImmuneBiologyProgramsSafetyCellsRegulatory T-LymphocyteFundingGrantTransplantationResearch PersonnelRecoveryMalignant NeoplasmsHematopoieticBaseCell TherapyStem CellsT-LymphocyteDoseRelapseAcute Graft Versus Host DiseasePreventProgenitor
Grant awards (51)
Off-the-Shelf Immune Effector Cells for Hematological Malignancies$2,080,518
P01 · FY2025 · CA · contact PI
Engineered CD4 Tregs Targeting B-ALL and AML$358,118
P01 · FY2025 · CA · contact PI
Administrative and Clinical Research Support Core$146,688
P01 · FY2025 · CA · contact PI
Transplant and Cellular Therapy$51,017
P30 · FY2025 · CA · contact PI
Off-the-Shelf Immune Effector Cells for Hematological Malignancies$1,982,660
P01 · FY2024 · CA · contact PI
Engineered CD4 Tregs Targeting B-ALL and AML$320,245
P01 · FY2024 · CA · contact PI
Administrative and Clinical Research Support Core$141,641
P01 · FY2024 · CA · contact PI
Transplant and Cellular Therapy$34,636
P30 · FY2024 · CA · contact PI
Off-the-Shelf Immune Effector Cells for Hematological Malignancies$2,101,526
P01 · FY2023 · CA · contact PI
Engineered CD4 Tregs Targeting B-ALL and AML$350,849
P01 · FY2023 · CA · contact PI
Administrative and Clinical Research Support Core$149,096
P01 · FY2023 · CA · contact PI
Transplant Biology and Therapy$48,471
P30 · FY2023 · CA · contact PI
Transplant Biology and Therapy$48,471
P30 · FY2022 · CA · contact PI
Transplant Biology and Therapy$48,471
P30 · FY2021 · CA · contact PI
Transplant Biology and Therapy$48,471
P30 · FY2020 · CA · contact PI
Biology and Transplantation of the Hematopoietic Stem Cell$1,857,651
P01 · FY2019 · CA · contact PI
Enhancing Lympho-Hematopoietic Recovery after Allogeneic UCBT$313,432
P01 · FY2019 · CA · contact PI
Administrative and Translational Research Support Core$215,797
P01 · FY2019 · CA · contact PI
Transplant Biology and Therapy$48,471
P30 · FY2019 · CA · contact PI
Biology and Transplantation of the Hematopoietic Stem Cell$1,914,832
P01 · FY2018 · CA · contact PI
Enhancing Lympho-Hematopoietic Recovery after Allogeneic UCBT$323,127
P01 · FY2018 · CA · contact PI
Administrative and Translational Research Support Core$222,470
P01 · FY2018 · CA · contact PI
Biology and Transplantation of the Hematopoietic Stem Cell$1,914,865
P01 · FY2017 · CA · contact PI
Enhancing Lympho-Hematopoietic Recovery after Allogeneic UCBT$323,127
P01 · FY2017 · CA · contact PI
Administrative and Translational Research Support Core$222,470
P01 · FY2017 · CA · contact PI
Biology and Transplantation of the Hematopoietic Stem Cell$1,914,901
P01 · FY2016 · CA · contact PI
Enhancing Lympho-Hematopoietic Recovery after Allogeneic UCBT$323,127
P01 · FY2016 · CA · contact PI
Administrative and Translational Research Support Core$222,470
P01 · FY2016 · CA · contact PI
Biology and Transplantation of the Hematopoietic Stem Cell$1,940,892
P01 · FY2015 · CA · contact PI
Enhancing Lympho-Hematopoietic Recovery after Allogeneic UCBT$325,393
P01 · FY2015 · CA · contact PI
Administrative and Translational Research Support Core$224,030
P01 · FY2015 · CA · contact PI
Biology & Transplantation of the Human Stem Cell$2,064,762
P01 · FY2014 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$315,233
P01 · FY2014 · CA · contact PI
Biology & Transplantation of the Human Stem Cell$2,042,270
P01 · FY2013 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$205,736
P01 · FY2013 · CA · contact PI
Transplant Biology & Therapy$77,835
P30 · FY2013 · CA · contact PI
Biology & Transplantation of the Human Stem Cell$2,148,642
P01 · FY2012 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$331,508
P01 · FY2012 · CA · contact PI
Transplant Biology & Therapy$38,148
P30 · FY2012 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$9,297
P01 · FY2012 · CA · contact PI
Transplant Biology & Therapy$2,678
P30 · FY2012 · CA · contact PI
Transplant Biology & Therapy$1,776
P30 · FY2012 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$332,653
P01 · FY2011 · CA · contact PI
Transplant Biology & Therapy$42,451
P30 · FY2011 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$989,074
P01 · FY2010 · CA · contact PI
Transplant Biology & Therapy$45,546
P30 · FY2010 · CA · contact PI
Transplant Biology & Therapy$44,253
P30 · FY2009 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$278,647
P01 · FY2006 · CA · contact PI
Enhancement of Lympho-Hematopoietic Recovery after UCBT$270,732
P01 · FY2005 · CA
TRANSPLANT CENTER FOR UMBILICAL CORD STEM CELL$97,487
N01 · FY2000 · HB
TRANSPLANT CENTER FOR UMBILICAL CORD STEM CELL$0
N01 · FY2000 · HB